Larry Bock
Special Limited Partner
Larry Bock is a Lux Capital Special Limited Partner and chairs Lux Ventures’ Advisory Board. He is also the Founder and Executive Director of the USA Science and Engineering Festival - the nation's largest celebration of science and engineering. Larry was a Co-Founder and Executive Chairman of Nanosys, Inc. Prior to Nanosys, he was a Managing General Partner of CW Group, a life sciences venture capital fund. Larry was also a General Partner of Avalon Ventures, a seed stage venture capital firm.
Larry has been the Founder and initial Chief Executive Officer of Metra Biosystems, Inc., Neurocrine Biosciences, Inc. (NASDAQ: NBIX - neuroimmunology), Pharmacopeia, Inc. (NASDAQ: PCOP - combinatorial chemistry), Argonaut Technologies, Inc. (NASDAQ: AGNT - combinatorial chemistry), and Caliper Technologies Corp. (NASDAQ: CALP - lab-on-a-chip). Mr. Bock was also a co-founder of ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA - intra cellular signal transduction), Athena Neurosciences (NASDAQ: ATHN, acquired by Elan Pharmaceuticals for $700M - molecular neurobiology) Inc., GenPharm International (acquired by MedaRx - transgenic animals), Vertex Pharmaceuticals, Inc. (NASDAQ: VRTX – rational drug design), Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX – molecular oncology) and Illumina, Inc. (NASDAQ: ILMN – array based optical sensors). He holds a B.A. in Liberal Arts from Bowdoin College and an M.B.A. from the Anderson School at the University of California, Los Angeles.
« Back to Team